Last update 01 Nov 2024
Ceftazidime/Sulbactam sodium
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), β-lactamase inhibitors(Beta Lactamase inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC8H11NNaO5S |
InChIKeySXKMQCSYTIDQTC-IBTYICNHSA-N |
CAS Registry69388-84-7 |
View All Structures (2)
Related
2
Clinical Trials associated with Ceftazidime/Sulbactam sodium评价注射用头孢他啶舒巴坦钠（2:1）治疗呼吸及泌尿系统中、重度急性细菌性感染的有效性和安全性II期临床试验
[Translation] Phase II clinical trial to evaluate the efficacy and safety of ceftazidime sulbactam sodium for injection (2:1) in the treatment of moderate to severe acute bacterial infections in the respiratory and urinary systems
注射用头孢他啶舒巴坦钠（2:1）治疗呼吸系统及泌尿系统中、重度急性细菌性感染有效性和安全性II期临床试验
[Translation] Phase II clinical trial on the efficacy and safety of ceftazidime sulbactam sodium for injection (2:1) in the treatment of moderate to severe acute bacterial infections in the respiratory and urinary systems
100 Clinical Results associated with Ceftazidime/Sulbactam sodium
Login to view more data
100 Translational Medicine associated with Ceftazidime/Sulbactam sodium
Login to view more data
100 Patents (Medical) associated with Ceftazidime/Sulbactam sodium
Login to view more data
100 Deals associated with Ceftazidime/Sulbactam sodium
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Bronchitis | Phase 2 | CN | 24 Nov 2011 | |
| Acute pyelonephritis | Phase 2 | CN | 24 Nov 2011 | |
| Bacterial Infections | Phase 2 | CN | 24 Nov 2011 | |
| Bronchiectasis | Phase 2 | CN | 24 Nov 2011 | |
| Lower urinary tract infectious disease | Phase 2 | CN | 24 Nov 2011 | |
| Pneumonia | Phase 2 | CN | 24 Nov 2011 | |
| Pulmonary Disease, Chronic Obstructive | Phase 2 | CN | 24 Nov 2011 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free